The Impact of Arnica Montana Following the Surgical Extraction of Impacted Third Molars

NCT ID: NCT06193720

Last Updated: 2024-01-05

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

10 participants

Study Classification

INTERVENTIONAL

Study Start Date

2022-02-03

Study Completion Date

2023-08-20

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Aim: The aim of this study is to evaluate the action of the homeopathic plant Arnica Montana on postoperative edema, pain and trismus after surgical extraction of impacted wisdom teeth.

Materials and Methods: The study is a double-blinded clinical trial recruiting patients undergoing surgical extraction of symmetrically impacted maxillary or mandibular third molars (right and left side). Patients receive alternately and randomly the verum (Arnica Montana 12 CH) or the placebo, in the form of capsules, to be taken 1 day prior to surgery and for 7 days postoperatively. Clinical parameters are collected and include: pain score, maximum mouth opening and facial measurements to assess edema's intensity.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Edema Pain Trismus

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

TRIPLE

Participants Caregivers Investigators

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Arnica Montana

Patients will take Arnica montana before and after surgery

Group Type EXPERIMENTAL

Arnica montana

Intervention Type DRUG

Assess the effect of arnica montana on pain, swelling ans trismus after impacted third molar surgery

Control

Patients will take placebo pills to compare the results

Group Type PLACEBO_COMPARATOR

Placebo

Intervention Type OTHER

Patients will take placebo drug after surgeries

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Arnica montana

Assess the effect of arnica montana on pain, swelling ans trismus after impacted third molar surgery

Intervention Type DRUG

Placebo

Patients will take placebo drug after surgeries

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Symmetrically impacted bilateral third molars (mandibular or maxillary).
* Young patients aged between 16 and 40 years old.
* No consumption of tobacco or coffee.
* Consent to the terms and conditions of the study.
* Good oral hygiene.
* ASA 1.

Exclusion Criteria

* Not symmetrically impacted third molars
* Patients with health problems
Minimum Eligible Age

16 Years

Maximum Eligible Age

40 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Saint-Joseph University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Christian Makary

Professor

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Saint Joseph University

Beirut, , Lebanon

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Lebanon

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

XFMD126

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Pain Control Following Third Molar Surgery
NCT06514222 ACTIVE_NOT_RECRUITING EARLY_PHASE1
Phytotherapy Agent in Third Molar Surgery
NCT03335683 COMPLETED PHASE4